A kind of fluticasone propionate quantitative inhalation aerosol
A technology of fluticasone propionate and flutica propionate, applied in inhalers, pharmaceutical formulas, medical preparations containing active ingredients, etc., can solve the problems of contaminated liquid medicine, hidden dangers, high price of storage tanks, etc., and it is not easy to achieve Drug particles, the effect of not easily adsorbed
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] Such as figure 1 Shown, a kind of fluticasone propionate metered inhalation aerosol, comprises aerosol preparation and the pressurized metered-dose inhaler that is used to contain this preparation, and described aerosol preparation comprises the active ingredient that is used for treating asthma or COPD and as described The liquefied propellant of the active ingredient solvent, the pressurized metered-dose inhaler includes a storage tank 1, a metering valve 2 and a driver 3, the material of the storage tank 1 is magnesium-aluminum alloy, and part of the inner surface of the storage tank 1 Or the entire inner surface is anodized, and the active ingredient is fluticasone propionate.
[0028] Specifically, the container 1 is used as a container for the aerosol preparation in the pressurized metered-dose inhaler. By setting the material of the container 1 as magnesium-aluminum alloy, the inner surface of the container 1 is partially or The entire surface is anodized, so th...
Embodiment 2
[0041] This embodiment is further limited on the basis of Example 1. In order to improve the therapeutic effect of the aerosol preparation, the fluticasone propionate is the micropowder obtained by air-pulverizing the bulk drug of fluticasone propionate. Further, the particle size of the above micropowder is between 2-4.5 microns, so that not only the surface of the storage tank 1 has less adsorption of the active ingredient, but also the active ingredient in the aerosol preparation can be effectively deposited in the lungs or on the trachea, thereby facilitating the improvement of the therapeutic effect of the aerosol.
[0042] In order to facilitate the proportioning of the aerosol while meeting the curative effect requirements, the content of the fluticasone propionate in the aerosol preparation is 0.05-0.43wt%.
[0043] In order to make the aerosol in the long-term storage process, the surface of the storage tank 1 has a very weak adsorption amount of active ingredients in...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
